(4-(4-Methylthiazol-5-yl)phenyl)methanamine hydrochloride, 97%, 5g

H-Ser(tBu)-OH, 95%, 500g

4-Bromo-3-(hydroxymethyl)benzoic acid, 95.0%, 1g

2-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)ethanone, 95.0%, 1g

tert-Butyl 4-(4-((benzyloxy)carbonyl)piperazin-1-yl)-2-chloro-5,8-dihydropyrido[3,4-d]pyrimidine-7(6H)-carboxylate, 1g

anti-Desmoglein 1/2 mouse monoclonal, DG 3.10, 0.2 ml

1,5-ANHYDRO-2,3,4-TRIDEOXY-2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-D-ERYTHROHEXITOL, 95.0%, 5g

3-Ethynylimidazo[1,2-a]pyridine, 95.0%, 1g

Methyl 2-tert-Butyloxycarbonylaminoacrylate, 95.0%, 1g

N-Methyl-N-pyrrolidin-3-yl-acetamide hydrochloride, 98%, 250mg

Ethyl 6-chloro-2-methylimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 10g

tert-Butyl (2-chlorothiazol-5-yl)carbamate, 97%, 5g

3-(1-Cyanoethyl)benzoic acid, 95.0%, 1kg